Showing results (631-640 of 718) with videos related to
Sort By:
Pageof 72
JTO Clinical and Research Reports|September 9, 2022
Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome SequencingSo Yeon Kim, Jun Yin, Stephen Bohlman, et al.Frontiers in Oncology|September 13, 2023
Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancerRobert Hsu, Denaly Chen, Bing Xia, et al.JTO Clinical and Research Reports|September 25, 2024
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 StudyJoel W Neal, Armando Santoro, Maria Gonzalez-Cao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and EtoposideMartin Reck, Tony S K Mok, Aaron Mansfield, et al.The Journal of Clinical Investigation|July 22, 2021
Targeting diacylglycerol lipase reduces alcohol consumption in preclinical modelsNathan D Winters, Gaurav Bedse, Anastasia A Astafyev, et al.Neuron|August 5, 2021
In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activityJordan S Farrell, Roberto Colangeli, Ao Dong, et al.JCI Insight|June 15, 2023
Circulating cell-free methylated DNA reveals tissue-specific, cellular damage from radiation treatmentMegan E McNamara, Netanel Loyfer, Amber J Kiliti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2017
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJoshua Bauml, Tanguy Y Seiwert, David G Pfister, et al.Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Outpatient Autologous Stem Cell Transplantation for Patients With MyelomaThomas M Paul, Stephen V Liu, Elise A Chong, et al.Cancer Chemotherapy and Pharmacology|August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumorsStephen V Liu, Susan G Groshen, Karen Kelly, et al.Pageof 72